Congress Wants EPO Answers; Companies Respond

Executive Briefing Series
KEYWORDS CapitolHill / Ethics
A A
A congressional committee has requested that Amgen and Johnson & Johnson (J&J) stop direct-to-consumer (DTC) advertising for erythropoiesis-stimulating agents (ESAs).

To View This Article:

Login